메뉴 건너뛰기
Annals of Neurology
Volumn 60, Issue 2, 2006, Pages A10-
Proteosome inhibitors revisited
Author keywords

[No Author keywords available]
Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALPHA SYNUCLEIN; DOPAMINE RECEPTOR STIMULATING AGENT; OXIDOPAMINE; PARAQUAT; PROTEASOME INHIBITOR; REAGENT; ROTENONE;
EID: 33746826885     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.20941     Document Type: Editorial
Times cited : (1)
References (12)
  • 1
    • 3042794162 scopus 로고    scopus 로고
    • Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
    • McNaught KS, Perl DP, Brownell AL, et al. Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease. Ann Neurol 2004;56:149-162.
    • (2004) Ann Neurol , vol.56 , pp. 149-162
    • McNaught, K.S.1    Perl, D.P.2    Brownell, A.L.3
  • 2
    • 33746834485 scopus 로고    scopus 로고
    • The proteosomal inhibition model of Parkinson's disease. "Boon or Bust"?
    • Lang AE, Beal MF. The proteosomal inhibition model of Parkinson's disease. "Boon or Bust"? Ann Neurol 2006;60: 158-161.
    • (2006) Ann Neurol , vol.60 , pp. 158-161
    • Lang, A.E.1    Beal, M.F.2
  • 3
    • 33746851548 scopus 로고    scopus 로고
    • Reproducible nigral cell loss following systemic proteasomal inhibitor administration to rats
    • Zeng B-Y, Bukhatwa S, Hikima A, et al. Reproducible nigral cell loss following systemic proteasomal inhibitor administration to rats. Ann Neurol 2006;60:248-252.
    • (2006) Ann Neurol , vol.60 , pp. 248-252
    • Zeng, B.-Y.1    Bukhatwa, S.2    Hikima, A.3
  • 4
    • 33746823308 scopus 로고    scopus 로고
    • Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons
    • Schapira A, Cleeter MWJ, Muddle J, et al. Proteasomal inhibition causes loss of nigral tyrosine hydroxylase neurons. Ann Neurol 2006;60:253-255.
    • (2006) Ann Neurol , vol.60 , pp. 253-255
    • Schapira, A.1    Cleeter, M.W.J.2    Muddle, J.3
  • 5
    • 33746791044 scopus 로고    scopus 로고
    • Lack of nigrostriatal pathology in a rat model of proteasome inhibition
    • Manning-Bog A, Reaney S, Chou V, et al. Lack of nigrostriatal pathology in a rat model of proteasome inhibition. Ann Neurol 2006;60:256-260.
    • (2006) Ann Neurol , vol.60 , pp. 256-260
    • Manning-Bog, A.1    Reaney, S.2    Chou, V.3
  • 6
    • 33746850545 scopus 로고    scopus 로고
    • Proteasome inhibition and Parkinson's disease modeling
    • Bove J, Zhou C, Jackson-Lewis V, et al. Proteasome inhibition and Parkinson's disease modeling. Ann Neurol 2006;60: 260-264.
    • (2006) Ann Neurol , vol.60 , pp. 260-264
    • Bove, J.1    Zhou, C.2    Jackson-Lewis, V.3
  • 7
    • 33746851988 scopus 로고    scopus 로고
    • Failure of protesome inhibitors to model Parkinson's disease in vivo
    • Kordower J, Kaanan N, Chu Y, et al. Failure of protesome inhibitors to model Parkinson's disease in vivo. Ann Neurol 2006;60:264-268.
    • (2006) Ann Neurol , vol.60 , pp. 264-268
    • Kordower, J.1    Kaanan, N.2    Chu, Y.3
  • 8
    • 33746839220 scopus 로고    scopus 로고
    • The proteasome inhibitor-induced model of Parkinson's disease
    • McNaught K, Olanow C. The proteasome inhibitor-induced model of Parkinson's disease. Ann Neurol 2006;60:243-247.
    • (2006) Ann Neurol , vol.60 , pp. 243-247
    • McNaught, K.1    Olanow, C.2
  • 9
    • 26844505808 scopus 로고    scopus 로고
    • Toxin-induced models of Parkinson's disease
    • Bove J, Prou D, Perier C, Przedborski S. Toxin-induced models of Parkinson's disease NeuroRx 2005;2:484-494.
    • (2005) NeuroRx , vol.2 , pp. 484-494
    • Bove, J.1    Prou, D.2    Perier, C.3    Przedborski, S.4
  • 10
    • 26844527655 scopus 로고    scopus 로고
    • Genetic mouse models of Parkinsonism: Strengths and limitations
    • Fleming SM, Fernagut P-O, Chesselet M-F. Genetic mouse models of Parkinsonism: strengths and limitations. NeuroRx 2005;2:495-503.
    • (2005) NeuroRx , vol.2 , pp. 495-503
    • Fleming, S.M.1    Fernagut, P.-O.2    Chesselet, M.-F.3
  • 11
    • 22144431885 scopus 로고    scopus 로고
    • Contradicted and initially stronger effects in highly cited clinical research
    • Iannidis JPA. Contradicted and initially stronger effects in highly cited clinical research JAMA 2005;294:218-228.
    • (2005) JAMA , vol.294 , pp. 218-228
    • Iannidis, J.P.A.1
  • 12
    • 33846563409 scopus 로고    scopus 로고
    • Why most published research findings are false
    • Ioannidis JPA. Why most published research findings are false. PLoS Med 2005;2:696-701.
    • (2005) PLoS Med , vol.2 , pp. 696-701
    • Ioannidis, J.P.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.